ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Earli, Inc.
A Contract Executive Assistant/Office Manager at Earli supports the executive team with calendar coordination, travel arrangements, and office operations, while fostering a connected team culture.
Headquarters
Redwood City, California, United States
Company Size
11-50 employees
Founded
2018
Earli is a biotechnology company whose mission is to make cancer a benign experience by forcing it to reveal and kill itself. The company uses AI to design genetic switches that program cancer cells to produce their own therapies, effectively turning tumors against themselves. Earli also develops synthetic biomarkers for early cancer detection, combining cutting-edge AI research and genetic engineering to transform how cancer is detected and treated.
AccentureAccenture Invests in Earli Inc. to Advance Technologies for Early Cancer Detection
Aug 19, 2024
Dark DailyWorld Economic Forum Publishes Updated List of 12 Breakthroughs in Fight against Cancer That Includes Innovative Clinical Laboratory Test (Part 1)
Nov 18, 2024
Mugglehead Investment MagazineEvaxion shares spike as AI-designed melanoma vaccine data hits market
Oct 15, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Earli, Inc. .
66% above the average for this role
Arlington's Sands Capital raises hefty sum for third life sciences fund
May 14, 2024